Effects on diffusing capacity and ventilation-perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD)

Respiratory Medicine

Volumn 95, Issue 8, 2001, Pages 676-684

  Sandek, K ^a   Bratel, T ^a   Lagerstrand, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic obstructive pulmonary disease; Diffusing capacity for carbon monoxide; Inhaled corticosteroids; Multiple inert gas elimination technique; Serum cortisol; Small airway disease; Ventilation perfusion ratios

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CARBON MONOXIDE; CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE; INERT GAS; IPRATROPIUM BROMIDE; LONG ACTING DRUG; THEOPHYLLINE;

ADULT; AGED; AIRWAY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; LUNG VENTILATION; LUNG VENTILATION PERFUSION RATIO; LUNG VOLUME; MALE; MONITORING; MORPHOLOGY; PREDICTION; PRIORITY JOURNAL; SPIROMETRY; VITAL CAPACITY;

EID: 0034864113     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1124     Document Type: Article

References (34)

1. Structural and inflammatory changes in COPD: A comparison with asthma
2. The National Institutes of Health intermittent positive-pressure breathing trial: Pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction
3. Immunopathology of the small airway submucosa in smokers with and without chronic obstructive pulmonary disease
4. +ve cells in the lungs of smokers with chronic obstructive pulmonary disease
5. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease
6. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema
7. Effects of long-term treatment with corticosteroids in COPD
8. A comparison of brochodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease
9. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease
10. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
11. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
12. Comparison of single breath carbon monoxide, diffusing capacity and pressure-volume curves in detecting emphysema
13. Lung structure and gas exchange in mild chronic obstructive pulmonary disease
14. Alveolar attachments in emphysema of human lungs
15. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy
16. Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men
17. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
18. Measurement of continuous distributions of ventilation-perfusion ratios: Theory
19. Estimation of ventilation-perfusion inequality by inert gas elimination without arterial sampling
20. Reproducibility of the multiple inert gas elimination technique
21. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals
22. 2
23. The effect of a new calcium Antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease
24. Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalisation
25. Cardiac function and central haemodynamics in severe chronic obstructive lung disease. Acute and long-term effects of felodipine
26. Pulmonary gas exchange in cystic fibrosis: Basal status and effect of i.v. antibiotics and inhaled amiloride
27. Standardised lung function testing
28. Defining the normal cortisol response to the short Synachten implications for the investigation of hypothalamic-pituitary disorders
29. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study
30. Ventilation-perfusion inequality and carbon dioxide sensitivity in hypoxaemic chronic obstructive pulmonary disease (COPD) and effects of long-term oxygen treatment (LTOT) for six months
31. Multi-breath and single breath helium dilution lung volumes as a test of airway obstruction
32. Changes in carbon monoxide transfer over 22 years in middle-aged men
33. Functional alterations accompanying a rapid decline in ventilatory function